Related references
Note: Only part of the references are listed.Inauhzin Sensitizes p53-Dependent Cytotoxicity and Tumor Suppression of Chemotherapeutic Agents
Yiwei Zhang et al.
NEOPLASIA (2013)
Inauhzin and Nutlin3 synergistically activate p53 and suppress tumor growth
Yiwei Zhang et al.
CANCER BIOLOGY & THERAPY (2012)
A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53
Qi Zhang et al.
EMBO MOLECULAR MEDICINE (2012)
Physical and Functional Interaction between Ribosomal Protein L11 and the Tumor Suppressor ARF
Mu-Shui Dai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Ubiquitin- and MDM2 E3 Ligase-independent Proteasomal Turnover of Nucleostemin in Response to GTP Depletion
Dorothy Lo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments
Nicholas T. Ingolia et al.
NATURE PROTOCOLS (2012)
Global Effect of Inauhzin on Human p53-Responsive Transcriptome
Jun-Ming Liao et al.
PLOS ONE (2012)
Structure and Activity Analysis of Inauhzin Analogs as Novel Antitumor Compounds That Induce p53 and Inhibit Cell Growth
Qi Zhang et al.
PLOS ONE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Highly Reproducible Label Free Quantitative Proteomic Analysis of RNA Polymerase Complexes
Amber L. Mosley et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo
Lei Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylase based on a cinnamic hydroxamic acid core structure
Liqiang Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Simultaneous determination of nucleotide sugars with ion-pair reversed-phase HPLC
Kazuki Nakajima et al.
GLYCOBIOLOGY (2010)
Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?
Katherine L. B. Borden et al.
LEUKEMIA & LYMPHOMA (2010)
The p53 orchestra: Mdm2 and Mdmx set the tone
Mark Wade et al.
TRENDS IN CELL BIOLOGY (2010)
Eukaryotic Polyribosome Profile Analysis
Anthony M. Esposito et al.
Jove-Journal of Visualized Experiments (2010)
Blinded by the Light: The Growing Complexity of p53
Karen H. Vousden et al.
CELL (2009)
Sirtuin inhibitors
Francisco J. Alcain et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2009)
Rtr1 Is a CTD Phosphatase that Regulates RNA Polymerase II during the Transition from Serine 5 to Serine 2 Phosphorylation
Amber L. Mosley et al.
MOLECULAR CELL (2009)
Mycophenolic acid activation of p53 requires ribosomal proteins l5 and l11
Xiao-Xin Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2
Mu-Shui Dai et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
5-fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction
Xiao-Xin Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Regulation of the interaction of inosine monophosphate dehydrogenase with mycophenolic acid by GTP
YS Ji et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Analysis of apoptosis by propidium iodide staining and flow cytometry
Carlo Riccardi et al.
NATURE PROTOCOLS (2006)
Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses
WY Chen et al.
CELL (2005)
Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma cells primarily via caspase-independent AIF/Endo G pathway
K Ishitsuka et al.
ONCOGENE (2005)
Synergy between imatinib and mycophenolic acid in inducing apoptosis in cell lines expressing Bcr-Abl
JJ Gu et al.
BLOOD (2005)
A multistep, GTP-driven mechanism controlling the dynamic cycling of nucleostemin
RYL Tsai et al.
JOURNAL OF CELL BIOLOGY (2005)
Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia -: Part I.: In vivo studies
K Malek et al.
LEUKEMIA RESEARCH (2004)
Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice
HL Cheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Induction of apoptosis in IL-3-dependent hematopoietic cell lines by guanine nucleotide depletion
JJ Gu et al.
BLOOD (2003)
The immunosuppressive agent mizoribine monophosphate forms a transition state analogue complex with inosine monophosphate dehydrogenase
L Gan et al.
BIOCHEMISTRY (2003)
Crystal structure of Tritrichomonas foetus inosine monophosphate dehydrogenase in complex with the inhibitor ribavirin monophosphate reveals a catalysis-dependent ion-binding site
GL Prosise et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase
H Vaziri et al.
CELL (2001)
Share Paper
